Deep Genomics

Deep Genomics company information, Employees & Contact Information

Explore related pages

Related company profiles:

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.

Company Details

Employees
92
Founded
-
Address
Mars Discovery District, Toronto,canada
Email
co****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Toronto.
HQ
Toronto
Looking for a particular Deep Genomics employee's phone or email?

Deep Genomics Questions

News

Thong Q. Le and Paul Sekhri Join Board of Directors at Deep Genomics - citybiz

Thong Q. Le and Paul Sekhri Join Board of Directors at Deep Genomics citybiz

BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence - PR Newswire

BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence PR Newswire

Deep Genomics Expands AI Platform for RNA Therapies - drugdiscoverytrends.com

Deep Genomics Expands AI Platform for RNA Therapies drugdiscoverytrends.com

Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm - BetaKit

Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm BetaKit

Deep Genomics raises $180 million to automate drug discovery - statnews.com

Deep Genomics raises $180 million to automate drug discovery statnews.com

Deep Genomics debuts AI model for debugging the body's RNA code and finding paths to potential therapies - Fierce Biotech

Deep Genomics debuts AI model for debugging the body's RNA code and finding paths to potential therapies Fierce Biotech

Deep Genomics Identifies AI-Discovered Candidate for Wilson Disease - Genetic Engineering and Biotechnology News

Deep Genomics Identifies AI-Discovered Candidate for Wilson Disease Genetic Engineering and Biotechnology News

Deep Genomics Appoints Brian O’Callaghan as CEO - citybiz

Deep Genomics Appoints Brian O’Callaghan as CEO citybiz

Deep Genomics Raises $180M in Series C Financing - Business Wire

Deep Genomics Raises $180M in Series C Financing Business Wire

U of T prof’s AI startup, Deep Genomics, raises US$180 million: The Globe and Mail - University of Toronto

U of T prof’s AI startup, Deep Genomics, raises US$180 million: The Globe and Mail University of Toronto

Deep Genomics Pitch Deck: SoftBank Leads $180 Million Series C Round - businessinsider.com

Deep Genomics Pitch Deck: SoftBank Leads $180 Million Series C Round businessinsider.com

Deep Genomics secures $226 million CAD led by SoftBank as it scales AI drug discovery platform - BetaKit

Deep Genomics secures $226 million CAD led by SoftBank as it scales AI drug discovery platform BetaKit

Deep Genomics founder: Why AI for drug discovery will far exceed current expectations - statnews.com

Deep Genomics founder: Why AI for drug discovery will far exceed current expectations statnews.com

Deep Genomics hits the partnering ground running with BioMarin deal - Fierce Biotech

Deep Genomics hits the partnering ground running with BioMarin deal Fierce Biotech

Deep Genomics Introduces the Most Advanced AI Foundation Model for RNA Disease Mechanisms and Candidate Therapeutics - Business Wire

Deep Genomics Introduces the Most Advanced AI Foundation Model for RNA Disease Mechanisms and Candidate Therapeutics Business Wire

Deep Genomics raises $40 million Series B for AI drug discovery platform - BetaKit

Deep Genomics raises $40 million Series B for AI drug discovery platform BetaKit

In conversation with Brendan Frey: Deep Genomics reveals the first-ever AI-discovered drug candidate - Fierce Biotech

In conversation with Brendan Frey: Deep Genomics reveals the first-ever AI-discovered drug candidate Fierce Biotech

Deep Genomics Appoints Jeffrey M. Brown, Ph.D., Vice President of Preclinical Research - Business Wire

Deep Genomics Appoints Jeffrey M. Brown, Ph.D., Vice President of Preclinical Research Business Wire

Deep Genomics Appoints Veteran Ferdinand Massari as Chief Medical Officer - Business Wire

Deep Genomics Appoints Veteran Ferdinand Massari as Chief Medical Officer Business Wire

Deep Genomics Applies Deep Learning to Gene Editing - Nanalyze

Deep Genomics Applies Deep Learning to Gene Editing Nanalyze

Branch retina vein occlusion combined with angle-closure glaucoma is associated with a mutation in BEST1: a case report - BMC Ophthalmology

Branch retina vein occlusion combined with angle-closure glaucoma is associated with a mutation in BEST1: a case report BMC Ophthalmology

U of T's Deep Genomics applies AI to accelerate drug development for genetic conditions - University of Toronto

U of T's Deep Genomics applies AI to accelerate drug development for genetic conditions University of Toronto

U of T's Deep Genomics inks partnership with U.S. biotech firm - University of Toronto

U of T's Deep Genomics inks partnership with U.S. biotech firm University of Toronto

AI startup Deep Genomics lands financing as it aims to ‘flip medicine on its back’ - The Globe and Mail

AI startup Deep Genomics lands financing as it aims to ‘flip medicine on its back’ The Globe and Mail

Top Deep Genomics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant